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Abstract
The incidence of lung abscess caused by Serratia marcescens is extremely low and is only reported in the immunocompromised 
population. We present a previously healthy woman with Serratia lung abscess in close proximity with an accessory cardiac 
bronchus. The patient was treated with appropriate antibiotics which led to complete resolution of the lesion. Our case highlights 
that individuals without medical co-morbidities may develop atypical lung infections like Serratia when associated with anatomic 
anomalies.
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Introduction
Previously, Serratia was considered a harm-
less nonpathogenic organism. However, over the 
past three decades, its importance as a causative 
agent for nosocomial and opportunistic infec-
tions has increasingly been recognized [1]. In 
the community setting, infections by Serratia 
marcescens are usually associated with immuno-
suppression or other serious medical comorbidi-
ties but are otherwise rarely seen [2]. This report 
describes a case where a rare congenital anomaly 
in a 64-year-old immunocompetent female was 
likely the predisposing factor for a Serratia lung 
abscess. To the best of our knowledge, Serratia 
lung abscess in a healthy individual without 
serious co-morbidities has not been reported in 
literature.
Case report 
We present a case of a previously healthy 
64-year-old female patient, who presented with 
fever and hemoptysis of two weeks duration. 
The fever was documented to be 38°C at home. 
Hemoptysis was mild in quantity and described 
as fresh red streaks of blood mixed with the spu-
tum. There was no history of night sweats, weight 
loss, or anorexia. There was no recent travel, sick 
contacts, or exposure to tuberculosis. She did not 
have history of any previous medical illnesses. 
She was a lifelong smoker, however she denied 
any illicit drug use. Patient sought medical atten-
tion prior to presentation, and completes a course 
of oral azithromycin without improvement.
On presentation, the patient was alert and 
communicative. She was not in acute distress. 
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Figure 2. Left image: Axial CECT shows the cardiac bronchus (curved white arrow) with an associated focal consolidation (white arrow). There is 
also accessory pulmonary vein (asterisk) draining to left atrium. Image to the right shows a follow-up axial CECT showing near-complete resolution 
of the consolidation after one-month
Figure 1. Coronal contrasted computed tomography (CCCT) shows a lobulated mass (asterisk) with hypo-attenuating center and thick peripheral 
contrast enhancement in the medial aspect of the superior segment of right lower lobe. The mass (asterisk) communicates with bronchial tree by 
an accessory cardiac bronchus arising from the medial wall of bronchus intermedius (curved arrow)
Her temperature was 36.9 degree Celsius orally, 
blood pressure was 104/62 mm Hg with a heart 
rate of 79 bpm, and oxygen saturation SpO2: 95%. 
Her lungs were clear to auscultation bilaterally 
with no added wheezes or crackles. Laboratory 
workup revealed a white count of 9,100/μL with 
normal differential, hemoglobin of 13.2 g/dL and 
platelet count of 411,000/L. Kidney function test 
and liver function tests were within normal. C-re-
active protein level was elevated (at 22.4 mg/L). 
Computed tomography (CT) of chest with 
contrast was performed which revealed a 3.2 
× 3.5 cm lobulated mass with hypo-attenuated 
center and thick peripheral contrast enhancement 
in the medial aspect of the superior segment of 
right lower lobe (Fig. 1). The mass had a commu-
nication to the bronchus intermedius by a small 
accessory bronchus arising from its medial wall. 
The accessory bronchus extended medially with 
distal tapering compatible with cardiac bronchus 
(Fig. 1). The mediastinum was remarkable for 
mildly enlarged subcarinal lymph node and an 
accessory pulmonary vein (Fig. 2) draining the 
posterior segment of right upper lobe and cour-
sing along the posterior and medial walls of what 
appeared to be a cardiac bronchus to left atrium.
Bronchoscopy revealed an obstruction of 
the right medial basilar segment orifice. En-
dobronchial brush and biopsy samples were 
normal. EBUS (Endo Bronchial Ultrasound) 
guided-fine needle aspirate from the suspicious 
mass and the enlarged subcarinal lymph nodes 
showed numerous acute inflammatory cells. BAL 
(broncho-alveolar lavage) culture grew Serratia 
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marcescens, which was sensitive to piperacillin, 
cefixime, ceftazidime, ceftriaxone, cefipime, az-
treonam, ertapenem, imipinem, meropenem, and 
ciprofloxacin. She was treated with intravenous 
ertapenem for 2 weeks followed by oral levofloxa-
cin for 2 weeks with significant clinical improve-
ment. A Follow up chest CT a month later showed 
near complete resolution of the abscess (Fig. 2). 
She has had no recurrence since this presentation.
Discussion 
This is a case of hemoptysis due to pulmo-
nary lung abscess caused by Serratia marcescens 
and concomitant accessory cardiac bronchus 
found incidentally. Serratia marcescens is a gram-
negative bacillus which belongs to the family 
Enterobacteriaceae [3]. It is a well-recognized 
nosocomial pathogen and rarely occurs in the 
community [1]. In the nosocomial setting, Serratia 
is usually transmitted by contaminated medical 
devices, fluids and cleaning solutions, or contact 
transmission via hospital staff [4]. In the com-
munity, it occurs mainly in illicit drug users, im-
munocompromised patients or those with severe 
medical comorbidities, such as diabetes mellitus, 
renal failure, steroid use, or malignancy [5–7]. 
Serratia infections have a quite low incidence 
of about 10.8/100,000 people every year [8]. Lung 
abscesses caused by Serratia marcescens are even 
rarer, with previous report indicating that only 
one of seventy four patients with Serratia mar-
cescens have lung abscesses [9]. We found very 
few cases in the literature that described lung 
abscess due to Serratia, all of which occurred in 
individuals who were immunocompromised or 
had significant co-morbidities as described above 
[10, 11]. Hence, it is very rare to diagnose a lung 
abscesses caused by Serratia in an immunocom-
petant patient. 
Formation of pulmonary abscesses is hastened 
by several factors including the local conditions, 
host resistance and infecting agents. Pulmonary 
abscesses are usually caused by aspiration, a prior 
pneumonia, alcohol abuse, bronchiectasis, immu-
nosuppression or an endobronchial obstruction [12]. 
In our case, the accessory cardiac bronchus most 
likely led to the development of the Serratia lung 
abscess. Accessory cardiac bronchus is a  rare 
congenital anomaly of the trachea-bronchial tree. 
It originates from the intermediate bronchus oppo-
site to the origin of the right upper lobe bronchus 
or from the medial wall of the right main bron-
chus, and it runs medially and caudally toward 
the heart [13, 14].
Most patients with accessory cardiac bron-
chus have no symptoms, and it is discovered 
incidentally during bronchoscopy or imaging 
studies conducted for evaluation of other tho-
racic problems. [13, 14]. However, an accessory 
cardiac bronchus can become symptomatic 
through hemoptysis, and recurrent infections 
especially if it is long or has an accessory lobe 
[13–15]. An explanation for these symptoms 
is the accumulation of secretions in the acces-
sory cardiac bronchus, leads to inflammation, 
extensive neovascularization and hemoptysis 
[14, 15]. In our patient’s  case, the accessory 
cardiac bronchus led to the formation of Ser-
ratia lung abscess. No treatment is required in 
asymptomatic and incidentally detected cases. 
However if it leads to recurrent infections or 
hemoptysis, the accessory cardiac bronchus 
should be resected [14].
Conclusions
This report describes a rare case of a com-
munity acquired Serratia lung abscess in an 
immunocompetent patient likely due to the pre-
sence of an accessory cardiac bronchus. Serratia 
marcescens  should always be a differential for 
lung abscess, especially in the correct context, ie. 
patients with attenuated immunity or structural 
abnormalities.
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